Notes to Consolidated Financial Statements 34 The Procter & Gamble Company and Subsidiaries Asset write-downs relate to the establishment of new carrying values  for assets held for sale or disposal. These assets represent excess capacity in the process of being removed from service or disposed as  well as businesses held for sale in the next 12 months. These assets  were written down to the amounts expected to be realized upon sale or disposal, less minor disposal costs. colorant market, while providing potential for significant synergies. The  operating results of the Clairol business are reported in the Company’s  beauty care segment from November 16, 2001. The following table provides pro forma results of operations for the  years ended June 30, 2002, 2001 and 2000, as if Clairol had been acquired as of the beginning of each fiscal year presented. The pro forma results include adjustments for estimated interest expense on acquisition debt and amortization of intangible assets, excluding goodwill and indefinite-lived intangibles. However, pro forma results do  not include any anticipated cost savings or other effects of the planned integration of Clairol. Accordingly, such amounts are not necessarily indicative of the results that would have occurred if the acquisition had  closed on the dates indicated, or that may result in the future.  Additionally, asset write-downs include certain manufacturing assets  that are expected to operate at levels significantly below their planned  capacity, primarily capital expansions related to recent initiatives that  have not met expectations. The projected cash flows from such assets  over their remaining useful lives are no longer estimated to be greater  than their current carrying values; therefore, they were written down to  estimated fair value, generally determined by reference to discounted  expected future cash flows. Such before-tax charges represented approximately $45 in 2002, $160 in 2001 and $0 in 2000. Charges for accelerated depreciation relate to long-lived assets that will  be taken out of service prior to the end of their normal service period  due to manufacturing consolidations, technology standardization, plant  closures or strategic choices to discontinue initiatives. The Company has  shortened the estimated useful lives of such assets, resulting in incremental depreciation expense.  Other costs incurred as a direct result of the program include relocation, training, certain costs associated with discontinuation of initiatives and the establishment of global business services and the  new legal and organization structure. The purchase method of accounting was used for acquisitions in all  periods presented. In 2002, acquisitions totaled $5.5 billion, resulting in  additions to goodwill of $3.6 billion and other intangible assets of $1.7  billion (see Note 4). These acquisitions consisted primarily of Clairol  along with an incremental payment for Dr. John’s Spinbrush. On November 16, 2001, the Company completed the acquisition of the Clairol business from the Bristol-Myers Squibb Company for  approximately $5.0 billion in cash, financed primarily with debt. Total  cash paid includes final purchase price adjustments based on a working  capital formula. The Clairol business consists of hair care, hair colorants  and personal care products, giving the Company entry into the hair  The Clairol acquisition resulted in $1,533 in total intangible assets acquired with $1,220 allocated to trademarks with indefinite lives. The  remaining $313 of acquired intangibles have determinable useful lives  and were assigned to trademarks of $128, patents and technology of  $146 and other intangible assets of $39. Total intangible assets acquired with determinable lives have a weighted average useful life of  9 years (11 years for trademarks, 9 years for patents and technology  and 5 years for other intangible assets). (1)  Approximately $2.6 billion is expected to be deductible for tax purposes.  The initial purchase price allocation of the Clairol business resulted in  the following condensed balance sheet of assets acquired and liabilities  assumed. It is anticipated that there will be changes to the initial allocation as fair values are finalized next quarter, but the Company  does not expect these changes to have a material impact on the results  of operations or financial condition of the Company in future periods. Asset Write-Downs Accelerated Depreciation Other Restructuring Charges Note 3 Acquisitions and Spin-off Acquisitions $40,801 2,927 $2.07  $41,488  3,517 $2.45 $40,780 4,406 $3.13 2002 Net sales Net earnings Diluted net earnings per common share Years Ended June 30 Pro forma results 2000 2001 $487 184 1,533 3,300 18  5,522  450 47 497  5,025 Current assets Property, plant and equipment Intangible assets Goodwill  (1) Other non-current assets Total assets acquired Current liabilities Non-current liabilities Total liabilities assumed Net assets acquired Opening Balance Millions of dollars except per share amounts